Skip to content

Novavax NVAX Business Segments — Selling, general, and administrative

Similar metrics at other companies

Arcutis Biotherapeutics, Inc. logo
ARQTReportable Segment — Selling, general, and administrative
$73.95M+15.8%
Twist Bioscience Corporation logo
TWSTReportable Segment — Selling, general and administrative expenses
$59.26M+25.3%
Century Aluminum logo
CENXReportable Segment — Selling, general and administrative expenses
$25.8M+106%
GXO Logistics logo
GXOReportable Segment — Selling, general and administrative expense
$280M+13.8%
Concentrix Corporation logo
CNXCReportable Segment — Selling, general and administrative expenses
$519.47M+7.2%
Eos Energy Enterprises, Inc. logo
EOSEReportable Segment — Selling, general and administrative expenses
$21.28M+41.7%

Other financials

Income statement

See full
Revenue$139.5M-79.1%
Gross profit$108.8M-83.3%
Operating income-$15.4M-103%
Net income-$9.5M-102%
EPS (diluted)-$0.06-102%

Balance sheet

See full
Cash & equivalents$228.4M-13.3%
Total debt$295.1M+404%
Total equity-$144.8M-91.4%
Total assets$1.0B-19.3%

Cash flow

See full
Operating cash flow-$32.4M+82.5%
CapEx$1.3M-20.4%
Free cash flow-$33.7M+82.0%

Valuation

See full
Market cap$1.46B+35.6%
Enterprise value$1.53B+76.9%
P/S2.5×+1.6×

Profitability

See full
Gross margin85%-2.5pp
Operating margin-13.1%-45.9pp
Net margin-14.7%-52.9pp
FCF margin-58.9%-61.4pp

Returns & leverage

See full
Return on equity-238.6%
Debt / equity1.5×
Current ratio2.5×+0.4×

Where this comes from

Reported directly by Novavax in its filing.

Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.

The official record: Novavax’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Novavax's business segments — selling, general, and administrative.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Novavax's business segments — selling, general, and administrative?
Novavax (NVAX) reported business segments — selling, general, and administrative of $28.78M in Q1 2026.
How has Novavax's business segments — selling, general, and administrative changed year-over-year?
Novavax's business segments — selling, general, and administrative decreased by 40.2% year-over-year, from $48.09M to $28.78M.
What is the long-term trend for Novavax's business segments — selling, general, and administrative?
Over 3 years (2022 to 2025), Novavax's business segments — selling, general, and administrative has grown at a -31.4% compound annual growth rate (CAGR), from $488.69M to $157.48M.
What does business segments — selling, general, and administrative mean?
Encompasses the operating expenses required to support the reportable segment's business activities, including marketing, sales, and general corporate overhead. It provides insight into the operational efficiency and the cost structure required to maintain the segment's market presence.